TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global and United States Cancer Biological Therapy Market Report & Forecast 2022-2028

Global and United States Cancer Biological Therapy Market Report & Forecast 2022-2028

  • Category:Life Sciences
  • Published on : 13 September 2022
  • Pages :112
  • Formats:
  • Report Code:SMR-7348301
OfferClick for best price

Best Price: $3480

Cancer Biological Therapy Market Size, Share 2022


Market Analysis and Insights: Global Cancer Biological Therapy Market

The global Cancer Biological Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Biological Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Biological Therapy market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Biological Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Biological Therapy market.

Global Cancer Biological Therapy Scope and Market Size

Cancer Biological Therapy market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Cancer Biological Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Cancer Biological Therapy market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

Monoclonal Antibodies

Vaccines

Cancer Growth Blockers

Blood Cell Growth Factors

Segment by Application

Hospitals

Diagnostic Laboratories

Research & Academic Laboratories

Pharmaceutical & Biotechnology Companies

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

By Company

ELI Lilly

Sanofi

Merck

Bayer

Roche

Novartis International

Pfizer

Bristol-Myers Squibb

Seattle Genetics

Amgen

Takeda Pharmaceuticals

GlaxoSmithKline

Spectrum Pharmaceuticals

Celgene Corporation

AstraZeneca, Plc.

Otsuka

Eisai

Abbvie

Incyte

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Cancer Biological Therapy product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Cancer Biological Therapy, with price, sales, revenue, and global market share of Cancer Biological Therapy from 2019 to 2022.

Chapter 3, the Cancer Biological Therapy competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Cancer Biological Therapy breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Cancer Biological Therapy market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Cancer Biological Therapy.

Chapter 13, 14, and 15, to describe Cancer Biological Therapy sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Cancer Biological Therapy Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global and United States Cancer Biological Therapy Market Report & Forecast 2022-2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 112 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Study Coverage
1.1 Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million) Introduction
1.2 Global Cancer Biological Therapy Outlook 2017 VS 2022 VS 2028
1.2.1 Global Cancer Biological Therapy Market Size for the Year 2017-2028
1.2.2 Global Cancer Biological Therapy Market Size for the Year 2017-2028
1.3 Cancer Biological Therapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Cancer Biological Therapy in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Cancer Biological Therapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Cancer Biological Therapy Market Dynamics
1.4.1 Cancer Biological Therapy Industry Trends
1.4.2 Cancer Biological Therapy Market Drivers
1.4.3 Cancer Biological Therapy Market Challenges
1.4.4 Cancer Biological Therapy Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Cancer Biological Therapy by Type
2.1 Cancer Biological Therapy Market Segment by Type
2.1.1 Monoclonal Antibodies
2.1.2 Vaccines
2.1.3 Cancer Growth Blockers
2.1.4 Blood Cell Growth Factors
2.2 Global Cancer Biological Therapy Market Size by Type (2017, 2022 & 2028)
2.3 Global Cancer Biological Therapy Market Size by Type (2017-2028)
2.4 United States Cancer Biological Therapy Market Size by Type (2017, 2022 & 2028)
2.5 United States Cancer Biological Therapy Market Size by Type (2017-2028)
3 Cancer Biological Therapy by Application
3.1 Cancer Biological Therapy Market Segment by Application
3.1.1 Hospitals
3.1.2 Diagnostic Laboratories
3.1.3 Research & Academic Laboratories
3.1.4 Pharmaceutical & Biotechnology Companies
3.2 Global Cancer Biological Therapy Market Size by Application (2017, 2022 & 2028)
3.3 Global Cancer Biological Therapy Market Size by Application (2017-2028)
3.4 United States Cancer Biological Therapy Market Size by Application (2017, 2022 & 2028)
3.5 United States Cancer Biological Therapy Market Size by Application (2017-2028)
4 Global Cancer Biological Therapy Competitor Landscape by Company
4.1 Global Cancer Biological Therapy Market Size by Company
4.1.1 Top Global Cancer Biological Therapy Companies Ranked by Revenue (2021)
4.1.2 Global Cancer Biological Therapy Revenue by Player (2017-2022)
4.2 Global Cancer Biological Therapy Concentration Ratio (CR)
4.2.1 Cancer Biological Therapy Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Cancer Biological Therapy in 2021
4.2.3 Global Cancer Biological Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Cancer Biological Therapy Headquarters, Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million) Type
4.3.1 Global Cancer Biological Therapy Headquarters and Area Served
4.3.2 Global Cancer Biological Therapy Companies Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Cancer Biological Therapy Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Cancer Biological Therapy Market Size by Company
4.5.1 Top Cancer Biological Therapy Players in United States, Ranked by Revenue (2021)
4.5.2 United States Cancer Biological Therapy Revenue by Players (2020, 2021 & 2022)
5 Global Cancer Biological Therapy Market Size by Region
5.1 Global Cancer Biological Therapy Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Cancer Biological Therapy Market Size by Region (2017-2028)
5.2.1 Global Cancer Biological Therapy Market Size by Region: 2017-2022
5.2.2 Global Cancer Biological Therapy Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Cancer Biological Therapy Market Size YoY Growth 2017-2028
6.1.2 North America Cancer Biological Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Cancer Biological Therapy Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Cancer Biological Therapy Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Cancer Biological Therapy Market Size YoY Growth 2017-2028
6.3.2 Europe Cancer Biological Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Cancer Biological Therapy Market Size YoY Growth 2017-2028
6.4.2 Latin America Cancer Biological Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Cancer Biological Therapy Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Cancer Biological Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 ELI Lilly
7.1.1 ELI Lilly Company Details
7.1.2 ELI Lilly Business Overview
7.1.3 ELI Lilly Cancer Biological Therapy Introduction
7.1.4 ELI Lilly Revenue in Cancer Biological Therapy Business (2017-2022)
7.1.5 ELI Lilly Recent Development
7.2 Sanofi
7.2.1 Sanofi Company Details
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Cancer Biological Therapy Introduction
7.2.4 Sanofi Revenue in Cancer Biological Therapy Business (2017-2022)
7.2.5 Sanofi Recent Development
7.3 Merck
7.3.1 Merck Company Details
7.3.2 Merck Business Overview
7.3.3 Merck Cancer Biological Therapy Introduction
7.3.4 Merck Revenue in Cancer Biological Therapy Business (2017-2022)
7.3.5 Merck Recent Development
7.4 Bayer
7.4.1 Bayer Company Details
7.4.2 Bayer Business Overview
7.4.3 Bayer Cancer Biological Therapy Introduction
7.4.4 Bayer Revenue in Cancer Biological Therapy Business (2017-2022)
7.4.5 Bayer Recent Development
7.5 Roche
7.5.1 Roche Company Details
7.5.2 Roche Business Overview
7.5.3 Roche Cancer Biological Therapy Introduction
7.5.4 Roche Revenue in Cancer Biological Therapy Business (2017-2022)
7.5.5 Roche Recent Development
7.6 Novartis International
7.6.1 Novartis International Company Details
7.6.2 Novartis International Business Overview
7.6.3 Novartis International Cancer Biological Therapy Introduction
7.6.4 Novartis International Revenue in Cancer Biological Therapy Business (2017-2022)
7.6.5 Novartis International Recent Development
7.7 Pfizer
7.7.1 Pfizer Company Details
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Cancer Biological Therapy Introduction
7.7.4 Pfizer Revenue in Cancer Biological Therapy Business (2017-2022)
7.7.5 Pfizer Recent Development
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Company Details
7.8.2 Bristol-Myers Squibb Business Overview
7.8.3 Bristol-Myers Squibb Cancer Biological Therapy Introduction
7.8.4 Bristol-Myers Squibb Revenue in Cancer Biological Therapy Business (2017-2022)
7.8.5 Bristol-Myers Squibb Recent Development
7.9 Seattle Genetics
7.9.1 Seattle Genetics Company Details
7.9.2 Seattle Genetics Business Overview
7.9.3 Seattle Genetics Cancer Biological Therapy Introduction
7.9.4 Seattle Genetics Revenue in Cancer Biological Therapy Business (2017-2022)
7.9.5 Seattle Genetics Recent Development
7.10 Amgen
7.10.1 Amgen Company Details
7.10.2 Amgen Business Overview
7.10.3 Amgen Cancer Biological Therapy Introduction
7.10.4 Amgen Revenue in Cancer Biological Therapy Business (2017-2022)
7.10.5 Amgen Recent Development
7.11 Takeda Pharmaceuticals
7.11.1 Takeda Pharmaceuticals Company Details
7.11.2 Takeda Pharmaceuticals Business Overview
7.11.3 Takeda Pharmaceuticals Cancer Biological Therapy Introduction
7.11.4 Takeda Pharmaceuticals Revenue in Cancer Biological Therapy Business (2017-2022)
7.11.5 Takeda Pharmaceuticals Recent Development
7.12 GlaxoSmithKline
7.12.1 GlaxoSmithKline Company Details
7.12.2 GlaxoSmithKline Business Overview
7.12.3 GlaxoSmithKline Cancer Biological Therapy Introduction
7.12.4 GlaxoSmithKline Revenue in Cancer Biological Therapy Business (2017-2022)
7.12.5 GlaxoSmithKline Recent Development
7.13 Spectrum Pharmaceuticals
7.13.1 Spectrum Pharmaceuticals Company Details
7.13.2 Spectrum Pharmaceuticals Business Overview
7.13.3 Spectrum Pharmaceuticals Cancer Biological Therapy Introduction
7.13.4 Spectrum Pharmaceuticals Revenue in Cancer Biological Therapy Business (2017-2022)
7.13.5 Spectrum Pharmaceuticals Recent Development
7.14 Celgene Corporation
7.14.1 Celgene Corporation Company Details
7.14.2 Celgene Corporation Business Overview
7.14.3 Celgene Corporation Cancer Biological Therapy Introduction
7.14.4 Celgene Corporation Revenue in Cancer Biological Therapy Business (2017-2022)
7.14.5 Celgene Corporation Recent Development
7.15 AstraZeneca, Plc.
7.15.1 AstraZeneca, Plc. Company Details
7.15.2 AstraZeneca, Plc. Business Overview
7.15.3 AstraZeneca, Plc. Cancer Biological Therapy Introduction
7.15.4 AstraZeneca, Plc. Revenue in Cancer Biological Therapy Business (2017-2022)
7.15.5 AstraZeneca, Plc. Recent Development
7.16 Otsuka
7.16.1 Otsuka Company Details
7.16.2 Otsuka Business Overview
7.16.3 Otsuka Cancer Biological Therapy Introduction
7.16.4 Otsuka Revenue in Cancer Biological Therapy Business (2017-2022)
7.16.5 Otsuka Recent Development
7.17 Eisai
7.17.1 Eisai Company Details
7.17.2 Eisai Business Overview
7.17.3 Eisai Cancer Biological Therapy Introduction
7.17.4 Eisai Revenue in Cancer Biological Therapy Business (2017-2022)
7.17.5 Eisai Recent Development
7.18 Abbvie
7.18.1 Abbvie Company Details
7.18.2 Abbvie Business Overview
7.18.3 Abbvie Cancer Biological Therapy Introduction
7.18.4 Abbvie Revenue in Cancer Biological Therapy Business (2017-2022)
7.18.5 Abbvie Recent Development
7.19 Incyte
7.19.1 Incyte Company Details
7.19.2 Incyte Business Overview
7.19.3 Incyte Cancer Biological Therapy Introduction
7.19.4 Incyte Revenue in Cancer Biological Therapy Business (2017-2022)
7.19.5 Incyte Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Cancer Biological Therapy Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Cancer Biological Therapy Market Trends
Table 3. Cancer Biological Therapy Market Drivers
Table 4. Cancer Biological Therapy Market Challenges
Table 5. Cancer Biological Therapy Market Restraints
Table 6. Global Cancer Biological Therapy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Cancer Biological Therapy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Cancer Biological Therapy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Cancer Biological Therapy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Cancer Biological Therapy Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Cancer Biological Therapy Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Cancer Biological Therapy Revenue Share by Player, 2017-2022
Table 13. Global Cancer Biological Therapy Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cancer Biological Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biological Therapy as of 2021)
Table 15. Top Players of Cancer Biological Therapy in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Cancer Biological Therapy Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Cancer Biological Therapy Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Cancer Biological Therapy Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Cancer Biological Therapy Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Cancer Biological Therapy Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Cancer Biological Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Cancer Biological Therapy Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Cancer Biological Therapy Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Cancer Biological Therapy Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Cancer Biological Therapy Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Cancer Biological Therapy Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Cancer Biological Therapy Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. ELI Lilly Company Details
Table 31. ELI Lilly Business Overview
Table 32. ELI Lilly Cancer Biological Therapy Product
Table 33. ELI Lilly Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
Table 34. ELI Lilly Recent Development
Table 35. Sanofi Company Details
Table 36. Sanofi Business Overview
Table 37. Sanofi Cancer Biological Therapy Product
Table 38. Sanofi Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
Table 39. Sanofi Recent Development
Table 40. Merck Company Details
Table 41. Merck Business Overview
Table 42. Merck Cancer Biological Therapy Product
Table 43. Merck Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
Table 44. Merck Recent Development
Table 45. Bayer Company Details
Table 46. Bayer Business Overview
Table 47. Bayer Cancer Biological Therapy Product
Table 48. Bayer Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
Table 49. Bayer Recent Development
Table 50. Roche Company Details
Table 51. Roche Business Overview
Table 52. Roche Cancer Biological Therapy Product
Table 53. Roche Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
Table 54. Roche Recent Development
Table 55. Novartis International Company Details
Table 56. Novartis International Business Overview
Table 57. Novartis International Cancer Biological Therapy Product
Table 58. Novartis International Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
Table 59. Novartis International Recent Development
Table 60. Pfizer Company Details
Table 61. Pfizer Business Overview
Table 62. Pfizer Cancer Biological Therapy Product
Table 63. Pfizer Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
Table 64. Pfizer Recent Development
Table 65. Bristol-Myers Squibb Company Details
Table 66. Bristol-Myers Squibb Business Overview
Table 67. Bristol-Myers Squibb Cancer Biological Therapy Product
Table 68. Bristol-Myers Squibb Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
Table 69. Bristol-Myers Squibb Recent Development
Table 70. Seattle Genetics Company Details
Table 71. Seattle Genetics Business Overview
Table 72. Seattle Genetics Cancer Biological Therapy Product
Table 73. Seattle Genetics Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
Table 74. Seattle Genetics Recent Development
Table 75. Amgen Company Details
Table 76. Amgen Business Overview
Table 77. Amgen Cancer Biological Therapy Product
Table 78. Amgen Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
Table 79. Amgen Recent Development
Table 80. Takeda Pharmaceuticals Company Details
Table 81. Takeda Pharmaceuticals Business Overview
Table 82. Takeda Pharmaceuticals Cancer Biological Therapy Product
Table 83. Takeda Pharmaceuticals Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
Table 84. Takeda Pharmaceuticals Recent Development
Table 85. GlaxoSmithKline Company Details
Table 86. GlaxoSmithKline Business Overview
Table 87. GlaxoSmithKline Cancer Biological Therapy Product
Table 88. GlaxoSmithKline Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
Table 89. GlaxoSmithKline Recent Development
Table 90. Spectrum Pharmaceuticals Company Details
Table 91. Spectrum Pharmaceuticals Business Overview
Table 92. Spectrum Pharmaceuticals Cancer Biological Therapy Product
Table 93. Spectrum Pharmaceuticals Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
Table 94. Spectrum Pharmaceuticals Recent Development
Table 95. Celgene Corporation Company Details
Table 96. Celgene Corporation Business Overview
Table 97. Celgene Corporation Cancer Biological Therapy Product
Table 98. Celgene Corporation Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
Table 99. Celgene Corporation Recent Development
Table 100. AstraZeneca, Plc. Company Details
Table 101. AstraZeneca, Plc. Business Overview
Table 102. AstraZeneca, Plc. Cancer Biological Therapy Product
Table 103. AstraZeneca, Plc. Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
Table 104. AstraZeneca, Plc. Recent Development
Table 105. Otsuka Company Details
Table 106. Otsuka Business Overview
Table 107. Otsuka Cancer Biological Therapy Product
Table 108. Otsuka Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
Table 109. Otsuka Recent Development
Table 110. Eisai Company Details
Table 111. Eisai Business Overview
Table 112. Eisai Cancer Biological Therapy Product
Table 113. Eisai Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
Table 114. Eisai Recent Development
Table 115. Abbvie Company Details
Table 116. Abbvie Business Overview
Table 117. Abbvie Cancer Biological Therapy Product
Table 118. Abbvie Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
Table 119. Abbvie Recent Development
Table 120. Incyte Company Details
Table 121. Incyte Business Overview
Table 122. Incyte Cancer Biological Therapy Product
Table 123. Incyte Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
Table 124. Incyte Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Cancer Biological Therapy Product Picture
Figure 2. Global Cancer Biological Therapy Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Cancer Biological Therapy Market Size 2017-2028 (US$ Million)
Figure 4. United States Cancer Biological Therapy Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Cancer Biological Therapy Market Size 2017-2028 (US$ Million)
Figure 6. United States Cancer Biological Therapy Market Share in Global 2017-2028
Figure 7. Cancer Biological Therapy Report Years Considered
Figure 8. Product Picture of Monoclonal Antibodies
Figure 9. Product Picture of Vaccines
Figure 10. Product Picture of Cancer Growth Blockers
Figure 11. Product Picture of Blood Cell Growth Factors
Figure 12. Global Cancer Biological Therapy Market Share by Type in 2022 & 2028
Figure 13. Global Cancer Biological Therapy Market Size by Type (2017-2028) & (US$ Million)
Figure 14. Global Cancer Biological Therapy Market Share by Type (2017-2028)
Figure 15. United States Cancer Biological Therapy Market Share by Type in 2022 & 2028
Figure 16. United States Cancer Biological Therapy Market Size by Type (2017-2028) & (US$ Million)
Figure 17. United States Cancer Biological Therapy Market Share by Type (2017-2028)
Figure 18. Product Picture of Hospitals
Figure 19. Product Picture of Diagnostic Laboratories
Figure 20. Product Picture of Research & Academic Laboratories
Figure 21. Product Picture of Pharmaceutical & Biotechnology Companies
Figure 22. Global Cancer Biological Therapy Market Share by Application in 2022 & 2028
Figure 23. Global Cancer Biological Therapy Market Size by Application (2017-2028) & (US$ Million)
Figure 24. Global Cancer Biological Therapy Market Share by Application (2017-2028)
Figure 25. United States Cancer Biological Therapy Market Share by Application in 2022 & 2028
Figure 26. United States Cancer Biological Therapy Market Size by Application (2017-2028) & (US$ Million)
Figure 27. United States Cancer Biological Therapy Market Share by Application (2017-2028)
Figure 28. North America Cancer Biological Therapy Market Size Growth Rate 2017-2028 (US$ Million)
Figure 29. U.S. Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. Canada Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. Europe Cancer Biological Therapy Market Size Growth Rate 2017-2028 (US$ Million)
Figure 32. Germany Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. France Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. U.K. Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Italy Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Russia Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Asia-Pacific Cancer Biological Therapy Market Size Growth Rate 2017-2028 (US$ Million)
Figure 38. China Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Japan Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. South Korea Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. India Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Australia Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Taiwan Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Indonesia Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Thailand Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Malaysia Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Philippines Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Latin America Cancer Biological Therapy Market Size Growth Rate 2017-2028 (US$ Million)
Figure 49. Mexico Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Brazil Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Argentina Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Middle East & Africa Cancer Biological Therapy Market Size Growth Rate 2017-2028 (US$ Million)
Figure 53. Turkey Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. U.A.E Cancer Biological Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 56. ELI Lilly Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
Figure 57. Sanofi Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
Figure 58. Merck Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
Figure 59. Bayer Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
Figure 60. Roche Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
Figure 61. Novartis International Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
Figure 62. Pfizer Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
Figure 64. Seattle Genetics Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
Figure 65. Amgen Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
Figure 66. Takeda Pharmaceuticals Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
Figure 67. GlaxoSmithKline Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
Figure 68. Spectrum Pharmaceuticals Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
Figure 69. Celgene Corporation Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
Figure 70. AstraZeneca, Plc. Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
Figure 71. Otsuka Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
Figure 72. Eisai Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
Figure 73. Abbvie Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
Figure 74. Incyte Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount